No Access
Industry Watch
https://doi.org/10.1142/S0219030307000031Cited by:0 (Source: Crossref)
Abstract
HD Medical and CSIRO Collaborate on Cardiac Diagnostics.
Medical Therapies Collaborates with NexMed.
Progen's Inventory Results on Phase 2 Liver Cancer Trial.
Renhuang Pharmaceuticals Announces Government Grant.
Mindray Medical to Establish New R&D and Manufacturing Base in Nanjing.
Sterlin Gelatin to Expand in India and China.
Favorable Decision Granted to Ranbaxy Laboratories on Pfizer's Australian Atorvastatin Patent.
Honeywell Automation India Ltd Plans to Expand into Emerging Indian Pharma Sector.
Bharat Biotech Launches Anti Rabies Vaccine — Rabirix.
Caliper Life Sciences Announces Expanded Sales on LabChip and Ivis.
Japan's Bioventures Today — ImmunoFrontier, Inc.
Keywords:
- Australia's National Scientific Research Agency
- Commonwealth Scientific and Industrial Research
- Competitive Commercializing Emerging Technologies grant
- Monash University Centre for Clinical Research Excellence
- Agribusiness sector
- Metallo-complexing technologies
- Hong Kong-based NexMed
- PI-88 increased disease-free survival
- Carbohydrate-protein interactions
- Nanjing Jiangning Development Zone
- Yangtze Delta region
- Ultrasound imaging systems
- People's Republic of China
- Heilongjiang Province
- State Food and Drug Administration
- Chromatographically purified vero cell vaccine
- Centre for Disease Control and Prevention
- Drug Controller General of India
- World Health Organization
- United States Food and Drug Administration
- European Medical Evaluation Agency
- National Institute of Virology
- Product-oriented research
- Korean Food & Drugs Administration
- Genome Valley
- Manufacturing execution system
- oncology
- Auto-immune and immunosuppressive drugs
- Atorvastatin
- Generic medicines
- Platform technologies
- Hypertension
- AIDS
- Asthma
- Parkinson's
- Huntington's disease
- Cartilage-related diseases
- Croda Colloids
- Caliper's LabChip and Ivis
- Microfluidics
